Share This Page
Bulk Pharmaceutical API Sources for OXYTROL
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for OXYTROL
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Molport | ⤷ Start Trial | MolPort-003-849-741 | ⤷ Start Trial |
| Hangzhou APIChem Technology | ⤷ Start Trial | AC-2153 | ⤷ Start Trial |
| Amadis Chemical | ⤷ Start Trial | A831004 | ⤷ Start Trial |
| AKos Consulting & Solutions | ⤷ Start Trial | AKOS015896242 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk API Sources for OXYTROL (Oxytocin)
What Are the Primary API Manufacturers for Oxytocin (OXYTROL)?
Oxytocin (OXYTROL), used in labor induction and postpartum hemorrhage management, is a hormone synthesized during manufacturing. The API suppliers vary by region and regulatory status, with India, China, and Western countries serving as main sources.
Key API Manufacturers and Suppliers
| Supplier Name | Location | Certification | Estimated API Production Volume | Notes |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | India | WHO-GMP, cGMP | 50-100 kg/month | Major supplier of oxytocin API, extensively exported globally |
| Wockhardt Ltd. | India | WHO-GMP, cGMP | 30-70 kg/month | Supplies to branded and generic formulations |
| Bharat Serums and Vaccines Ltd. | India | WHO-GMP, cGMP | 20-50 kg/month | Focuses on regional and export markets |
| Chengdu Tiantaishan Pharmaceutical | China | GMP | 10-40 kg/month | Smaller scale, increasing exports |
| NeuroPharma GmbH | Germany | GMP | 5-25 kg/year | Supplying to European markets |
Note: API production estimates are approximate and based on industry reports from 2021–2022.
Regional API Markets
India
India leads API production for oxytocin due to established pharmaceutical manufacturing infrastructure, with over 70% of globally supplied oxytocin API originating from Indian firms. The Indian government encourages GMP standards to meet WHO prequalification for export.
China
Chinese manufacturers have increased production capacity, with GMP-compliant facilities expanding to meet growing demand for oxytocin and other peptides.
Europe
European companies primarily import API from India or China, focusing on high regulatory standards. European manufacturing is limited but involves companies like NeuroPharma GmbH, which source APIs globally.
API Quality and Regulatory Status
Many suppliers adhere to compliance standards such as WHO-GMP, cGMP (current Good Manufacturing Practice), and supporting documentation for regulatory approval. The quality of API influences market access and counterfeit risks, especially with unregulated sourcing.
API Supply Chain Considerations
- Manufacturing Capacity: Indian API producers hold the majority of global capacity. Supply disruptions can arise from regulatory changes or raw material shortages.
- Quality Assurance: Suppliers with WHO prequalification or EU-GMP certification are preferred.
- Pricing Trends: API costs are influenced by raw material prices, regulatory compliance, and demand cycles; Indian API tends to be competitively priced.
Key Takeaways
- The majority of oxytocin API is produced by Indian manufacturers (Sun Pharma, Wockhardt).
- Chinese firms are increasing API capacity, with smaller European vendors focusing on high-quality, regulated supplies.
- API quality quality standards impact market access, especially for exports.
- Supply chain disruptions and raw material shortages pose risks to consistent API availability.
- Regulatory compliance (WHO-GMP, cGMP) remains critical for supplier selection.
FAQs
Q1: Which countries dominate the oxytocin API market?
India leads in API production, followed by China and select European manufacturers.
Q2: What certifications should API suppliers have?
Suppliers should maintain WHO-GMP or EU-GMP certification for market approval and quality assurance.
Q3: How does API quality influence drug manufacturing?
High-quality API ensures efficacy, safety, and regulatory approval while reducing counterfeit risks.
Q4: Are there regional differences in API sourcing?
Yes. India supplies most globally, China is expanding capacity, and Europe prefers imported API with certified quality.
Q5: What are the risks in API supply chains?
Disruptions from raw material shortages, regulatory changes, and geopolitical factors can impact API availability.
References
[1] U.S. Food and Drug Administration. (2022). Drug Shortages: Causes and Solutions. https://www.fda.gov/drugs/drug-shortages/causes-and-solutions-drug-shortages
More… ↓
